Lil Nas X’s bipolar diagnosis and the paradox of treatment
Lil Nas X’s bipolar diagnosis and the paradox of treatment
Services: AI superintelligence for autonomous lab-based experimentation compressing R&D cycles from decades to months. Science superintelligence platform for drug discovery and materials science. | Leadership: Geoffrey von Maltzahn (Co-Founder & CEO, Flagship Pioneering), Chief Scientist (TBD) | Keywords: AI drug discovery, autonomous labs, scientific superintelligence, robotics, machine learning
Lil Nas X’s bipolar diagnosis and the paradox of treatment